Nondefense Discretionary Science 2013 Survey: Unlimited Potential, Vanishing Opportunity
AMERICAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY ROCKVILLE MD
Pagination or Media Count:
Research labs are to the national scientific enterprise what small businesses are to the American economy. Individual labs, funded by federal grants for research, employ young scientists and make the discoveries that tech companies capitalize on. Corporations like Apple, Pfizer and Boeing, to name a few, have built their success on pioneering discoveries made by federally funded scientists working at American universities. This pipeline of discovery and commercialization pays real dividends for the American taxpayer--research in American labs and commercialized by American companies leading to a 1 percent drop in the yearly cancer mortality rate saves the U.S. 500 billion per year in health care costs. The information technology sector, built largely on discoveries made by federally funded scientists, contributes nearly 1 trillion per year to the U.S. gross domestic product. Thus, the federal investment in scientific research has been, and continues to be, repaid to the U.S. government and the American taxpayer many times over. However, over the past 10 years, the federal investment in research and development has faltered. Federal investments in scientific research have been stagnant and have failed to keep pace with inflation. Furthermore, sequestration and other budget cuts to federal agencies have eroded our ability to invest in the next generation of scientists to carry out the groundbreaking research the U.S. is known for. These trends must be reversed in order for American scientists to continue to make the discoveries that improve our lives. An enduring federal investment in scientific research is essential to continue to enrich the lives of Americans for decades to come.
- Medicine and Medical Research
- Test Facilities, Equipment and Methods